Kaplan–Meier analyses revealed that patients with high GALNT6 expressing lung adenocarcinoma had a significantly shorter survival than those with low GALNT6 expression (P = 0.006, Fig. 1b). Here, GALNT6 is linked to lung adenocarcinoma.